Portman, Neil http://orcid.org/0000-0003-0248-0258
Milioli, Heloisa H.
Alexandrou, Sarah
Coulson, Rhiannon
Yong, Aliza
Fernandez, Kristine J.
Chia, Kee Ming
Halilovic, Ensar
Segara, Davendra
Parker, Andrew
Haupt, Sue
Haupt, Ygal
Tilley, Wayne D.
Swarbrick, Alex
Caldon, C. Elizabeth
Lim, Elgene
Funding for this research was provided by:
National Breast Cancer Foundation (IIRS-19-053, EC17-002, PRAC14-02)
Cancer Institute NSW (ECF171156)
Breast Cancer Trials - Australia and New Zealand (N/A)
The Estate of the Late RT Hall (N/A)
Love Your Sister (N/A)
Article History
Received: 5 February 2020
Accepted: 21 July 2020
First Online: 12 August 2020
Ethics approval and consent to participate
: All in vivo experiments, procedures and endpoints were approved by the Garvan Institute of Medical Research Animal Ethics Committee (protocol 15/25). PDX models were collected with patient consent under approval from Royal Prince Alfred Hospital human research ethics committee (HREC/13/RPA/187 - KCC_P_3837) and St Vincent’s Hospital human research ethics committee (HREC/H2006/2633 - Gar15-13).
: Not applicable.
: Funding and drugs for this study were provided under a research agreement with Novartis Australia.EL provides advisory board services to Novartis Australia, Roche Australia, Specialised Therapeutics Australia, Pfizer Australia, Lilly Australia and Amgen Australia (<i>All honoraria paid to the Garvan Institute of Medical Research</i>).EH is an employee at Novartis.